Advertisement

Advertisement


European Perspectives


Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort Survey

Florence Canouï-Poitrine, Astrid Lièvre, Florent Dayde, Daniel Lopez-Trabada-Ataz, Isabelle Baumgaertner, Olivier Dubreuil, Francesco Brunetti, Romain Coriat, Karin Maley, Simon Pernot, Christophe Tournigand, Meoin Hagege, Thomas Aparicio, Elena Paillaud, Sylvie Bastuji-Garin

The Oncologist first published on July 19, 2019; doi:10.1634/theoncologist.2019-0166


Prospective Biomarker Study in Advanced RAS Wild-Type Colorectal Cancer: POSIBA Trial (GEMCAD 10-02)

Xabier García-Albéniz, Vicente Alonso, Pilar Escudero, Miguel Méndez, Javier Gallego, Jose Ramon Rodríguez, Antonia Salud, Julen Fernández-Plana, Hermini Manzano, Montserrat Zanui, Ester Falcó, Jaime Feliu, Mireia Gil, Carlos Fernández‐Martos, Uriel Bohn, Carmen Alonso, Veró
nica Calderero, Federico Rojo, Miriam Cuatrecasas, Joan Maurel

The Oncologist first published on June 24, 2019; doi:10.1634/theoncologist.2018-0728


Long-Term Survivors in Metastatic Pancreatic Ductal Adenocarcinoma: A Retrospective and Matched Pair Analysis

Pauline Rochefort, Audrey Lardy-Cleaud, Matthieu Sarabi, Françoise Desseigne, Anne Cattey-Javouhey, Christelle de la Fouchardière

The Oncologist first published on June 4, 2019; doi:10.1634/theoncologist.2018-0786


Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1-T3, N0-N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE Study

Maria Vittoria Dieci, Valentina Guarneri, Fable Zustovich, Marta Mion, Paolo Morandi, Emilio Bria, Laura Merlini, Pierluigi Bullian, Cristina Oliani, Stefania Gori, Tommaso Giarratano, Enrico Orvieto, Gaia Griguolo, Silvia Michieletto, Tania Saibene, Paola Del Bianco, Gian Luca De Salvo, PierFranco Conte, on behalf of the Veneto Oncology Network

The Oncologist first published on May 31, 2019; doi:10.1634/theoncologist.2019-0103


Characteristics of BRAFV600E Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients

Christelle de la Fouchardiére, Romain Cohen, David Malka, Rosine Guimbaud, Héloïse Bourien, Astrid Lièvre, Wulfran Cacheux, Pascal Artru, Eric François, Marine Gilabert, Emmanuelle Samalin-Scalzi, Aziz Zaanan, Vincent Hautefeuille, Benoit Rousseau, Hélène Senellart, Romain Coriat, Ronan Flippot, Françoise Desseigne, Audrey Lardy-Cleaud, David Tougeron

The Oncologist first published on May 31, 2019; doi:10.1634/theoncologist.2018-0914


Prognostic Nomogram and Patterns of Use of FOLFIRI-Aflibercept in Advanced Colorectal Cancer: A Real-World Data Analysis

Ana Fernández Montes, Carlos López López, Guillem Argilés Martínez, David Páez López, Ana María López Muñoz, Beatriz García Paredes, David Gutiérrez Abad, Carmen Castañón López, Paula Jiménez Fonseca, Javier Gallego Plazas, María Carmen López Doldán, Eva Martínez de Castro, Manuel Sánchez Cánovas, María Tobeña Puyal, Beatriz Llorente Ayala, Ignacio Juez Martel, Mariana López Flores, Alberto Carmona-Bayonas

The Oncologist first published on May 30, 2019; doi:10.1634/theoncologist.2018-0824


Conformity to Clinical Practice Guidelines at Initial Management in Adult Soft Tissue and Visceral Tumors since the Implementation of the NetSarc Network in Eastern France

Justine Gantzer, Antonio Di Marco, Thibaut Fabacher, Noelle Weingertner, Jean-Baptiste Delhorme, David Brinkert, Guillaume Bierry, Jean‐Pierre Ghnassia, Jérémie Jégu, Jean-Emmanuel Kurtz

The Oncologist first published on May 9, 2019; doi:10.1634/theoncologist.2018-0751


Prevention, Monitoring, and Management of Cardiac Dysfunction in Patients with Metastatic Breast Cancer

Giuseppe Curigliano, Evandro de Azambuja, Daniel Lenihan, Maria Grazia Calabrò, Daniela Cardinale, Carlo Maria Cipolla

The Oncologist first published on May 7, 2019; doi:10.1634/theoncologist.2018-0773


Adjuvant Zoledronic Acid in High-Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial

Astrid Lipplaa, Judith R. Kroep, Lizz van der Heijden, Paul C. Jutte, Pancras C.W. Hogendoorn, Sander Dijkstra, Hans Gelderblom

The Oncologist first published on April 30, 2019; doi:10.1634/theoncologist.2019-0280


A Pilot, Phase II, Randomized, Open-Label Clinical Trial Comparing the Neurotoxicity of Three Dose Regimens of Nab-Paclitaxel to That of Solvent-Based Paclitaxel as the First-Line Treatment for Patients with Human Epidermal Growth Factor Receptor Type 2-Negative Metastatic Breast Cancer

Eva Ciruelos, María Apellániz-Ruiz, Blanca Cantos, Noelia Martinez-Jáñez, Coralia Bueno-Muiño, Maria‐Jose Echarri, Santos Enrech, Juan-Antonio Guerra, Luis Manso, Tomas Pascual, Cristina Dominguez, Juan-Francisco Gonzalo, Juan-Luis Sanz, Cristina Rodriguez-Antona, Juan-Manuel Sepúlveda

The Oncologist first published on April 25, 2019; doi:10.1634/theoncologist.2017-0664


Outcome of Patients with Soft-Tissue Sarcomas: An Age-Specific Conditional Survival Analysis

Kevin Bourcier, Derek Dinart, Axel Le Cesne, Charles Honoré, Pierre Meeus, Jean-Yves Blay, Audrey Michot, François Le Loarer, Antoine Italiano

The Oncologist first published on April 23, 2019; doi:10.1634/theoncologist.2018-0641


Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors

Alberto Pavan, Lorenzo Calvetti, Alessandro Dal Maso, Ilaria Attili, Paola Del Bianco, Giulia Pasello, Valentina Guarneri, Giuseppe Aprile, PierFranco Conte, Laura Bonanno

The Oncologist first published on April 23, 2019; doi:10.1634/theoncologist.2018-0563


Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population

Lucio Crinò, Paolo Bidoli, Angelo Delmonte, Francesco Grossi, Filippo De Marinis, Andrea Ardizzoni, Fabiana Vitiello, Giuseppe Lo Russo, Hector Soto Parra, Enrico Cortesi, Federico Cappuzzo, Luana Calabrò, Marcello Tiseo, Daniele Turci, Teresa Gamucci, Paola Antonelli, Alessandro Morabito, Antonio Chella, Diana Giannarelli, Domenico Galetta

The Oncologist first published on April 17, 2019; doi:10.1634/theoncologist.2018-0737


"How Long Have I Got?"-A Prospective Cohort Study Comparing Validated Prognostic Factors for Use in Patients with Advanced Cancer

Claribel Simmons, Donald C. McMillan, Sharon Tuck, Cat Graham, Alistair McKeown, Mike Bennett, Claire O'Neill, Andrew Wilcock, Caroline Usborne, Kenneth C. Fearon, Marie Fallon, Barry J. Laird, on behalf of the IPAC Study Group

The Oncologist first published on April 11, 2019; doi:10.1634/theoncologist.2018-0474


Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma

Rocio Garcia-Carbonero, Ivan Marquez-Rodas, Luis de la Cruz-Merino, Javier Martinez-Trufero, Miguel Angel Cabrera, Jose Maria Piulats, Jaume Capdevila, Enrique Grande, Salvador Martin-Algarra, Alfonso Berrocal

The Oncologist first published on April 8, 2019; doi:10.1634/theoncologist.2018-0718


HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer

Andrea Sartore-Bianchi, Alessio Amatu, Luca Porcu, Silvia Ghezzi, Sara Lonardi, Francesco Leone, Francesca Bergamo, Elisabetta Fenocchio, Erika Martinelli, Beatrice Borelli, Federica Tosi, Patrizia Racca, Emanuele Valtorta, Emanuela Bonoldi, Cosimo Martino, Caterina Vaghi, Giovanna Marrapese, Fortunato Ciardiello, Vittorina Zagonel, Alberto Bardelli, Livio Trusolino, Valter Torri, Silvia Marsoni, Salvatore Siena

The Oncologist first published on April 5, 2019; doi:10.1634/theoncologist.2018-0785


Circulating Tumor Cells Identify Patients with Super-High-Risk Non-Muscle-Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single-Center Trial

Chiara Nicolazzo, Gian Maria Busetto, Angela Gradilone, Isabella Sperduti, Francesco del Giudice, Flavia Loreni, Enrico Cortesi, Ettore de Berardinis, Paola Gazzaniga, Cristina Raimondi

The Oncologist first published on April 3, 2019; doi:10.1634/theoncologist.2018-0784


Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice

Alessandro Broccoli, Beatrice Casadei, Annalisa Chiappella, Carlo Visco, Monica Tani, Nicola Cascavilla, Annarita Conconi, Monica Balzarotti, Maria Christina Cox, Dario Marino, Maria Cecilia Goldaniga, Roberto Marasca, Cristina Tecchio, Caterina Patti, Gerardo Musuraca, Liliana Devizzi, Federico Monaco, Alessandra Romano, Angelo Fama, Michelle Zancanella, Rossella Paolini, Luigi Rigacci, Claudia Castellino, Francesco Gaudio, Lisa Argnani, Pier Luigi Zinzani

The Oncologist first published on April 2, 2019; doi:10.1634/theoncologist.2018-0603


Twenty Years with Personalized Medicine: Past, Present, and Future of Individualized Pharmacotherapy

Jan Trøst Jørgensen

The Oncologist first published on April 2, 2019; doi:10.1634/theoncologist.2019-0054


The EMA Review of Mylotarg (Gemtuzumab Ozogamicin) for the Treatment of Acute Myeloid Leukemia

Sahra Ali, Helen-Marie Dunmore, Dominik Karres, Justin L. Hay, Tomas Salmonsson, Christian Gisselbrecht, Sinan B. Sarac, Ole W. Bjerrum, Doris Hovgaard, Yolanda Barbachano, Nithyanandan Nagercoil, Francesco Pignatti

The Oncologist first published on March 21, 2019; doi:10.1634/theoncologist.2019-0025


Care for Smoking Cessation Must Be Proactive and Based on a Combination of Pharmacology and Psychology

Alain Braillon

The Oncologist first published on March 19, 2019; doi:10.1634/theoncologist.2018-0817


Inequalities in Financial Distress, Symptoms, and Quality of Life Among Patients with Advanced Cancer in France and the U.S.

Cécile Barbaret, Marvin O. Delgado-Guay, Stéphane Sanchez, Christelle Brosse, Murielle Ruer, Léa Monsarrat, Patrick Michaud, Anne Marie Schott, Eduardo Bruera, Mariléne Filbet

The Oncologist first published on March 15, 2019; doi:10.1634/theoncologist.2018-0353


Inhibition of Serotonin Synthesis May Have Antitumor Activity? Long‐Term Efficacy in a Patient with Gastrointestinal Neuroendocrine Tumor

Javier Molina‐Cerrillo, Enrique Grande, Teresa Alonso‐Gordoa

The Oncologist first published on March 15, 2019; doi:10.1634/theoncologist.2018-0776


Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)

Sanchez, Sergio Vázquez, Narayanan Srihari, Haralabos Kalofonos, Petri Bono, Chaitali Babanrao Pisal, Yulia Hirschberg, Luca Dezzani, Qasim Ahmad, Eric Jonasch, on behalf of the PRINCIPAL Study Group

The Oncologist first published on March 13, 2019; doi:10.1634/theoncologist.2018-0787


From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study)

Giulia Pasello, Giovanni Vicario, Fable Zustovich, Francesco Oniga, Stefania Gori, Francesco Rosetti, Andrea Bonetti, Adolfo Favaretto, Silvia Toso, Roberta Redelotti, Antonio Santo, Daniele Bernardi, Petros Giovanis, Cristina Oliani, Lorenzo Calvetti, Carlo Gatti, Giovanni Palazzolo, Zora Baretta, Alberto Bortolami, Laura Bonanno, Marco Basso, Jessica Menis, Donatella Da Corte, Stefano Frega, Valentina Guarneri, PierFranco Conte, on behalf of Veneto Oncology Network

The Oncologist first published on March 7, 2019; doi:10.1634/theoncologist.2018-0712


The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer

Emne A. Abdallah, Alexcia C. Braun, Bianca C.T.C.P. Flores, Laís Senda, Ana Cláudia Urvanegia, Vinicius Calsavara, Victor Hugo Fonseca de Jesus, Maria Fernanda Arruda Almeida, Maria Dirlei Begnami, Felipe J.F. Coimbra, Wilson Luiz da Costa Jr, Diana Noronha Nunes, Emmanuel Dias-Neto, Ludmilla T. Domingos Chinen

The Oncologist first published on March 7, 2019; doi:10.1634/theoncologist.2018-0741


Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study

Alessio Cortellini, Sebastiano Buti, Daniele Santini, Fabiana Perrone, Raffaele Giusti, Marcello Tiseo, Melissa Bersanelli, Maria Michiara, Antonino Grassadonia, Davide Brocco, Nicola Tinari, Michele De Tursi, Federica Zoratto, Enzo Veltri, Riccardo Marconcini, Francesco Malorgio, Carlo Garufi, Marco Russano, Cecilia Anesi, Tea Zeppola, Marco Filetti, Paolo Marchetti, Andrea Botticelli, Gian Carlo Antonini Cappellini, Federica De Galitiis, Maria Giuseppa Vitale, Roberto Sabbatini, Sergio Bracarda, Rossana Berardi, Silvia Rinaldi, Marianna Tudini, Rosa Rita Silva, Annagrazia Pireddu, Francesco Atzori, Rita Chiari, Biagio Ricciuti, Daniela Iacono, Maria Rita Migliorino, Antonio Rossi, Giampiero Porzio, Katia Cannita, Valeria Ciciarelli, Maria Concetta Fargnoli, Paolo Antonio Ascierto, Corrado Ficorella

The Oncologist first published on February 22, 2019; doi:10.1634/theoncologist.2018-0618


Postsurgical Approaches in Low-Grade Oligodendroglioma: Is Chemotherapy Alone Still an Option?

Enrico Franceschi, Alicia Tosoni, Dario De Biase, Giuseppe Lamberti, Daniela Danieli, Stefano Pizzolitto, Elena Zunarelli, Michela Visani, Enrico Di Oto, Antonella Mura, Santino Minichillo, Chiara Scafati, Sofia Asioli, Alexandro Paccapelo, Stefania Bartolini, Alba A. Brandes

The Oncologist first published on February 18, 2019; doi:10.1634/theoncologist.2018-0549/p>


Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement

Ramon Colomer, Cristina Saura, Pedro Sánchez-Rovira, Tomás Pascual, Isabel T. Rubio, Octavio Burgués, Lourdes Marcos, César A. Rodríguez, Miguel Martín, Ana Lluch

The Oncologist first published on February 1, 2019; doi:10.1634/theoncologist.2018-0228


Changes in the Use of Comprehensive Geriatric Assessment in Clinical Trials for Older Patients with Cancer over Time

Olivia Le Saux, Claire Falandry, Hui K. Gan, Benoit You, Gilles Freyer, Julien Péron

The Oncologist first published on February 1, 2019; doi:10.1634/theoncologist.2018-0493


Suspected Hereditary Cancer Syndromes in Young Patients: Heterogeneous Clinical and Genetic Presentation of Colorectal Cancers

Claudia Maletzki, Maja Hühns, Ingrid Bauer, Friedrich Prall, Christian Junghanss, Larissa Henze

The Oncologist first published on on January 25, 2019; doi:10.1634/theoncologist.2018-0614


Everolimus plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO-2

Aleix Prat, Jan Christoph Brase, Yuan Cheng, Paolo Nuciforo, Laia Paré, Tomás Pascual, Débora Martínez, Patricia Galván, Maria Vidal, Barbara Adamo, Gabriel N. Hortobagyi, José Baselga, Eva Ciruelos

The Oncologist first published on January 24, 2019; doi:10.1634/theoncologist.2018-0407


Diagnosis and Treatment Monitoring of a Patient with Gastrointestinal Stromal Tumor by Next‐Generation Sequencing and Droplet Digital Polymerase Chain Reaction Assay of a PDGFRA Mutation in Plasma‐Derived Cell‐Free Tumor DNA

Pieter A. Boonstra, Arja ter Elst, Marco Tibbesma, Jourik A. Gietema, Ed Schuuring, Anna K.L. Reyners

The Oncologist first published on January 22, 2019; doi:10.1634/theoncologist.2018-0460


Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group

Gabriel G. Malouf, Guillaume Beinse, Julien Adam, Olivier Mir, Ali N. Chamseddine, Philippe Terrier, Charles Honore, Jean-Philippe Spano, Antoine Italiano, Jean-Emmanuel Kurtz, Jean-Michel Coindre, Jean-Yves Blay, Axel Le Cesne

The Oncologist first published on January 9, 2019; doi:10.1634/theoncologist.2018-0074


T-Cell Lymphopenia in Patients with Advanced Thyroid Carcinoma Is Associated with Poor Prognosis

Katrin Rabold, Paul R. Gielen, Esther D. Kers-Rebel, Mihai G. Netea, Jan W.A. Smit, Gosse J. Adema, Romana T. Netea-Maier

The Oncologist first published on January 3, 2019; doi:10.1634/theoncologist.2018-0422


Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

Claudio Vernieri, Fabio Galli, Laura Ferrari, Paolo Marchetti, Sara Lonardi, Evaristo Maiello, Rosario V. Iaffaioli, Maria G. Zampino, Alberto Zaniboni, Sabino De Placido, Maria Banzi, Azzurra Damiani, Daris Ferrari, Gerardo Rosati, Roberto F. Labianca, Paolo Bidoli, Giovanni L. Frassineti, Mario Nicolini, Lorenzo Pavesi, Maria C. Tronconi, Angela Buonadonna, Sabrina Ferrario, Giovanni Lo Re, Vincenzo Adamo, Emiliano Tamburini, Mario Clerico, Paolo Giordani, Francesco Leonardi, Sandro Barni, Andrea Ciarlo, Luigi Cavanna, Stefania Gori, Saverio Cinieri, Marina Faedi, Massimo Aglietta, Maria Antista, Katia F. Dotti, Francesca Galli, Maria Di Bartolomeo, on behalf of TOSCA (Three or Six Colon Adjuvant) Investigators

The Oncologist first published on January 3, 2019; doi:10.1634/theoncologist.2018-0442


Impact of Comorbidities and Age on Cause-Specific Mortality in Postmenopausal Patients with Breast Cancer

Marloes G.M. Derks, Cornelis J.H. van de Velde, Daniele Giardiello, Caroline Seynaeve, Hein Putter, Johan W.R. Nortier, Luc Y. Dirix, Esther Bastiaannet, Johanneke E.A. Portielje, Gerrit-Jan Liefers

The Oncologist first published on January 3, 2019; doi:10.1634/theoncologist.2018-0010


Nasoethmoidal Intestinal-Type Adenocarcinoma Treated with Cetuximab: Role of Liquid Biopsy and BEAMing in Predicting Response to Anti-Epidermal Growth Factor Receptor Therapy

Santiago Cabezas-Camarero, Virginia de la Orden García, Vanesa García-Barberán, Beatriz Mediero-Valeros, Ahmad Issa Subhi-Issa, Patricia Llovet García, Inmaculada Bando-Polaino, Salomé Merino Menéndez, Pedro Pérez-Segura, Eduardo Díaz-Rubio

The Oncologist first published on January 2, 2019; doi:10.1634/theoncologist.2018-0387


Depressive Symptom Profiles and Survival in Older Patients with Cancer: Latent Class Analysis of the ELCAPA Cohort Study

Clément Gouraud, Elena Paillaud, Claudia Martinez-Tapia, Lauriane Segaux, Nicoleta Reinald, Marie Laurent, Lola Corsin, Nicolas Hoertel, Mathilde Gisselbrecht, Elise Mercadier, Pascaline Boudou-Rouquette, Anne Chahwakilian, Sylvie Bastuji-Garin, Frédéric Limosin, Cédric Lemogne, Florence Canouï-Poitrine, on behalf of the ELCAPA Study Group

The Oncologist first published on December 31, 2018; doi:10.1634/theoncologist.2018-0322


Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer

Elisabetta Pietri, Ilaria Massa, Sara Bravaccini, Sara Ravaioli, Maria Maddalena Tumedei, Elisabetta Petracci, Caterina Donati, Alessio Schirone, Federico Piacentini, Lorenzo Gianni, Mario Nicolini, Enrico Campadelli, Alessandra Gennari, Alessandro Saba, Beatrice Campi, Linda Valmorri, Daniele Andreis, Francesco Fabbri, Dino Amadori, Andrea Rocca

The Oncologist first published on December 27, 2018; doi:10.1634/theoncologist.2018-0243


Efficacy of Single-Agent Chemotherapy for Patients with Advanced Invasive Lobular Carcinoma: A Pooled Analysis from Three Clinical Trials

José Pérez-Garcia, Javier Cortés, Otto Metzger Filho

The Oncologist first published on December 21, 2018; doi:10.1634/theoncologist.2018-0182


Long-Term Gynecological Cancer Survivors in Côte d'Or: Health-Related Quality of Life and Living Conditions

Ariane Mamguem Kamga, Agnés Dumas, Florence Joly, Oumar Billa, Julien Simon, Marie-Laure Poillot, Ariane Darut-Jouve, Charles Coutant, Pierre Fumoleau, Patrick Arveux, Tienhan Sandrine Dabakuyo-Yonli

The Oncologist first published on December 21, 2018; doi:10.1634/theoncologist.2018-0347


Safety and Activity of Sorafenib in Addition to Vinflunine in Post‐Platinum Metastatic Urothelial Carcinoma (Vinsor): Phase I Trial

Carl-Henrik Shah, Helle Pappot, Mads Agerbæk, Karin Holmsten, Fredrik Jäderling, Jeffrey Yachnin, Per Grybäck, Hans von der Maase, Anders Ullén

The Oncologist first published on December 14, 2018; doi:10.1634/theoncologist.2018-0795


Treatment Outcomes and Sensitivity to Hormone Therapy of Aggressive Angiomyxoma: A Multicenter, International, Retrospective Study

Giovanni Fucá, Nadia Hindi, Isabelle Ray-Coquard, Vittoria Colia, Angelo Paolo Dei Tos, Javier Martin-Broto, Mehdi Brahmi, Paola Collini, Domenica Lorusso, Francesco Raspagliesi, Maria Abbondanza Pantaleo, Bruno Vincenzi, Elena Fumagalli, Alessandro Gronchi, Paolo Giovanni Casali, Roberta Sanfilippo

The Oncologist first published on December 5, 2018; doi:10.1634/theoncologist.2018-0338


How Does a Supervised Exercise Program Improve Quality of Life in Patients with Cancer? A Concept Mapping Study Examining Patients' Perspectives

Maike G. Sweegers, Laurien M. Buffart, Wouke M. van Veldhuizen, Edwin Geleijn, Henk M.W. Verheul, Johannes Brug, Mai J.M. Chinapaw, Teatske M. Altenburg

The Oncologist first published on November 13, 2018; doi:10.1634/theoncologist.2017-0613


Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE

Silvana Leo, Ermenegildo Arnoldi, Lazzaro Repetto, Zaira Coccorullo, Saverio Cinieri, Palma Fedele, Marina Cazzaniga, Vito Lorusso, Agnese Latorre, Giovanna Campanella, Mariangela Ciccarese, Caterina Accettura, Salvatore Pisconti, Antonio Rinaldi, Cosimo Brunetti, Mimma Raffaele, Luigi Coltelli, Salvatore Spazzapan, Lucia Fratino, Luciana Petrucelli, Laura Biganzoli

The Oncologist first published on November 9, 2018; doi:10.1634/theoncologist.2017-0676


Relevance of Reference Centers in Sarcoma Care and Quality Item Evaluation: Results from the Prospective Registry of the Spanish Group for Research in Sarcoma (GEIS)

Javier Martin-Broto, Nadia Hindi, Josefina Cruz, Javier Martinez-Trufero, Claudia Valverde, Luis M. De Sande, Angeles Sala, Lorena Bellido, Ana De Juan, Jordi Rubió-Casadevall, Roberto Diaz-Beveridge, Ricardo Cubedo, Oscar Tendero, Diego Salinas, Isidro Gracia, Rafael Ramos, Silvia Baguè, Antonio Gutierrez, José Duran-Moreno, Antonio Lopez-Pousa

The Oncologist first published on November 8, 2018; doi:10.1634/theoncologist.2018-0121


Symptom Expression in Patients with Advanced Cancer Admitted to an Acute Supportive/Palliative Care Unit With and Without Delirium

Sebastiano Mercadante, Claudio Adile, Patrizia Ferrera, Andrea Cortegiani, Alessandra Casuccio

The Oncologist first published on October 24, 2018; doi:10.1634/theoncologist.2018-0244


A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma

Alba A. Brandes, Miguel Gil-Gil, Frank Saran, Antoine F. Carpentier, Anna K. Nowak, Warren Mason, Vittorina Zagonel, François Dubois, Gaetano Finocchiaro, George Fountzilas, Dana Michaela Cernea, Oliver Chinot, Rodica Anghel, Francois Ghiringhelli, Patrick Beauchesne, Giuseppe Lombardi, Enrico Franceschi, Martina Makrutzki, Chiedzo Mpofu, Hans-Joerg Urban, Josef Pichler

The Oncologist first published on September 28, 2018; doi:10.1634/theoncologist.2018-0290


Cosmetic Consequences of Breast-Conserving Treatment for Breast Cancer: Something Worth Talking About

Angelique Brands-Appeldoorn, Sabrina Maaskant-Braat, Karin Schenk, Rudi Roumen

The Oncologist first published on September 26, 2018; doi:10.1634/theoncologist.2017-0443


Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors

Sebastien Gouy, Alexandra Arfi, Amandine Maulard, Patricia Pautier, Enrica Bentivegna, Alexandra Leary, Cyrus Chargari, Catherine Genestie, Philippe Morice

The Oncologist first published on September 10, 2018; doi:10.1634/theoncologist.2017-0632


“I need to know what makes somebody tick …”: Challenges and Strategies of Implementing Shared Decision-Making in Individualized Oncology

Joschka Haltaufderheide, Sebastian Wäscher, Bernhard Bertlich, Jochen Vollmann, Anke Reinacher-Schick, Jan Schildmann

The Oncologist first published on September 6, 2018; doi:10.1634/theoncologist.2017-0615


Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study

Eric Van Cutsem, Erika Martinelli, Stefano Cascinu, Alberto Sobrero, Maria Banzi, Jean-François Seitz, Carlo Barone, Marc Ychou, Marc Peeters, Baruch Brenner, Ralf Dieter Hofheinz, Evaristo Maiello, Thierry André, Andrea Spallanzani, Rocio Garcia-Carbonero, Yull E. Arriaga, Udit Verma, Axel Grothey, Christian Kappeler, Ashok Miriyala, Joachim Kalmus, Alfredo Falcone, Alberto Zaniboni

The Oncologist first published on September 6, 2018; doi:10.1634/theoncologist.2018-0072


Minimal Increase in Survival Throughout the Years in Patients with Soft Tissue Sarcoma with Synchronous Metastases: Results of a Population-Based Study

Melissa Vos, Vincent K. Y. Ho, Astrid W. Oosten, Cornelis Verhoef, Stefan Sleijfer

The Oncologist first published on on September 6, 2018; doi:10.1634/theoncologist.2017-0383


Expenditures on Oncology Drugs and Cancer Mortality-to-Incidence Ratio in Central and Eastern Europe

Eduard Vrdoljak, Gyorgy Bodoky, Jacek Jassem, Razvan Popescu, Robert Pirker, Tanja Čufer, Semir Bešlija, Alexandru Eniu, Vladimir Todorović, Katerina Kopećková, Galia Kurteva, Zorica Tomaševič, Agim Sallaku, Snezhana Smichkoska, Žarko Bajić, Branimir Sikic

The Oncologist first published on September 4, 2018; doi:10.1634/theoncologist.2018-0093


European Articles Archive

Links to other domains will open in a new tab or window.